MSD
This high-visibility role combines integrated cross-functional program leadership with deep subject-matter expertise in biologics analytical development. As an Early-Stage DCT Leader, you will provide strategic, technical, and operational direction for integrated CMC teams, advancing a portfolio of pipeline biologics from candidate selection through early clinical development and First-in-Human milestones. The position also involves serving as an analytical SME to guide method development, drive analytical control strategies, and champion robust characterization to enable swift pipeline progression.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Senior Scientist, Analytical Research and Development - Onsite
Merck & Co., Inc.
Principal Scientist
Merck & Co., Inc.
Analytical Scientist, Large Molecule
Elanco
Associate Principal Scientist, Biologics Analytical Research & Development
Merck & Co., Inc.
Principal Research Scientist I, Biologics Analytical Research & Development
AbbVie
Sr Research Associate, Analytical Operations
Gilead Sciences